AI & Machine Learning
FinalDose
Programmable DNA drug destroying all cancers, unlocking 80% of targets
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
- Therapeutics
- Artificial Intelligence
- Gene Therapy
- Website
- finaldose.ai
- Headquarters
- Oxford, England, United Kingdom
- Team size
- 2-10 people
- Founded
- 2026
- Demo
- 45 min demo
Similar companies
Evolvere BioSciencesMaking Next-Generation Antibiotics that Outpace Bacterial Evolution
ParcelBioElevated mRNA for transformative medicines.
Rejuvenation Technologies Inc.mRNA therapeutics to extend healthspan entering clinical trials
ZavoUnlocking the world’s most valuable data for frontier AI.
AutomatAgentic automation that understands context, recovers, and improves.
cloud humansAI-powered customer service for startups
ParallelAI agents for healthcare admin
MindeeAI Document Understanding API